Ongoing Disclosure Notice – Brent Douglas King

To NZX Limited; and
Name of listed issuer:
General Capital LimitedGeneral Capital Limited
Date this disclosure made:
8/10/20218/10/2021
Date of last disclosure:
28/09/202128/09/2021
Director or senior manager giving disclosure
Full name(s):
Brent Douglas KingBrent Douglas King
Name of listed issuer:
General Capital LimitedGeneral Capital Limited
Name of related body corporate (if applicable):
N/AN/A
Position held in listed issuer:
DirectorDirector
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Ordinary Shares
Nature of the affected relevant interest(s):
Registered owner and
beneficial owner
Brent King as sole director of Barter Investments Limited has the power to exercise the
rights (including voting rights) of the General Capital Limited Ordinary Shares held by
Barter Investments Limited.
For that relevant interest-
Number held in class before acquisition or disposal:
21,948,650 3,562,470
Number held in class after acquisition or disposal:
22,115,317 -
Current registered holder(s):
Barter Investments LimitedBarter Investments Limited
Registered holder(s) once transfers are registered:
Brent Douglas King
1. 1,333,333 ordinary shares transferred to SAJE Limited.
2. 1,000,000 ordinary shares transferred to Anthony Edwin Falkenstein and Heather
Jeanette Falkenstein.
3. 666,667 ordinary shares transferred to the Paretovich Bartlett Family Trust.
4. 229,136 ordinary shares transferred to Josephine Hanham and Noel Hanham
5. 166,667 ordinary shares transferred to Garth William Ward.
6. 166,667 ordinary shares transferred to Brent Douglas King.
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional
amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or
physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of
the consideration payable under the derivative or the value
of the derivative is affected by the value of the underlying
financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the
derivative, the nature of the relevant interest in the
derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1 Transaction6 Transactions
Details of transactions requiring disclosure-
Date of transaction:8/10/2021
8/10/2021
Nature of transaction:
Name of any other party or parties to the transaction (if
known):Barter Investments Limited
1. 1,333,333 ordinary shares transferred to SAJE Limited.
2. 1,000,000 ordinary shares transferred to Anthony Edwin Falkenstein and Heather
Jeanette Falkenstein.
3. 666,667 ordinary shares transferred to the Paretovich Bartlett Family Trust.
4. 229,136 ordinary shares transferred to Josephine Hanham and Noel Hanham
5. 166,667 ordinary shares transferred to Garth William Ward.
6. 166,667 ordinary shares transferred to Brent Douglas King.
The consideration, expressed in New Zealand dollars, paid
or received for the acquisition or disposal. If the
consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
None. Transfer done as part
of winddown of Barter
Investements Limited.
None. Transfer done as part of winddown of Barter Investements Limited.

Number of financial products to which the transaction
related:
166,667 3,562,470
Whether relevant interests were acquired or disposed of
during a closed period:YesYes
Whether prior written clearance was provided to allow the
acquisition or disposal to proceed during the closed period:
YesYes
Date of the prior written clearance (if any):8/10/20218/10/2021
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
GENWB Warrants
Nature of relevant interest:
Registered owner and
beneficial owner
For that relevant interest,-
Number held in class:
53,897,300
Current registered holder(s):
Brent Douglas King
The notional value of the derivative (if any) or the notional
amount of underlying financial products (if any):
(a) 53,897,300 GENWB
warrants (conversion ratio of
one ordinary share for every
one warrant held if exercised)
(b) 4,250,000 June 2023
Warrants.
(c) 4,250,000 June 2024
Warrants.
A statement as to whether the derivative is cash settled or
physically settled:
Cash Settled
Maturity date of the derivative (if any):
(a) Last exercise date of
30/11/2021
(b) Last exercise date of
30/06/2023
(c) Last exercise date of
30/06/2024
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following
details—

Expiry date of the derivative (if any):
(a) Last exercise date of
30/11/2021
(b) Last exercise date of
30/06/2023
(c) Last exercise date of
30/06/2024
The price's specified terms (if any):
(a) 9.00 cents per share on
the exercise of each warrant
(b) 8.00 cents per share on
the exercise of each warrant
(c) 9.00 cents per share on
the exercise of each warrant
Any other details needed to understand how the amount of
the consideration payable under the derivative or the value
of the derivative is affected by the value of the underlying
financial products:
N/A
For that derivative relevant interest,-
Parties to the derivative: Brent Douglas King
If the director or senior manager is not a party to the
derivative, the nature of the relevant interest in the
derivative:
N/A
Certification
I, certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I
am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:8/10/2021
or
Signature of person authorised to sign on behalf of director
or officer:
Date of signature:
Name and title of authorised person: